产品中心Cell Resources
联系我们CONTACT US
400-999-210024小时服务热线
产品概述
| 名称 | LNCaP clone FGC (人前列腺癌细胞) (STR鉴定正确) |
| 别称 | LNCaP-Clone-FGC; LNCaP.FGC; LNCaP-FGC; LNCaP FGC; LNCaP-ATCC |
| 种属 | 人 |
| 生长特性 | 贴壁细胞 |
| 细胞形态 | 上皮细胞样 |
| 冻存条件 | 冻存液：55% 基础培养基+40%FBS+5%DMSO 温度：液氮 |
| 培养方案A（默认） |
培养条件:
气相：空气，95%；CO2，5%, 温度：37℃
|
| 推荐传代比例 | 1:3-1:4 |
| 推荐换液频率 | 2-3次/周 |
| 注意事项 | 1.该细胞并不形成一致的单层，而是形成集落。2.该细胞会使培养基快速变酸，且生长缓慢，故传代后 48 小时内不应扰动；3.普通TC处理的培养瓶或皿不能使细胞很好的贴壁，培养难度较高，需使用 Corning 的 cellbind 细胞培养瓶（货号是 3289），或者使用多聚-L-赖氨酸溶液（货号 PB180523）包被过的培养皿；4.在细胞运输途中，多数细胞会从培养瓶底分离，大片悬浮在培养基中，按照收货注意事项处理即可恢复正常。 |
| 背景描述 | 人前列腺癌细胞LNCaP clone FGC是从一位50岁白人男性(血型B+)的左锁骨淋巴结针刺活检中分离，该患者经确诊为前列腺癌转移。LNCaP clone FGC细胞对5-α-二氢睾酮(生长调节子和酸性磷酸脂酶产物)有响应。LNCaP clone FGC细胞并不形成一致的单层，而是形成集落，在传代时可以用滴管反复吹吸打碎。LNCaP clone FGC细胞仅仅轻轻地吸附在基底上，不形成汇合，很快使培养基变酸。LNCaP clone FGC细胞生长极其缓慢，传代后48小时内不应扰动。当培养瓶封包后，多数LNCaP clone FGC细胞从培养瓶底分离，悬浮在培养基中。收到后，在通常培养单层细胞的条件下培养24-48小时，以使细胞再贴壁。此后，可以换上新鲜培养液。如果需要，培养瓶内容物可以收集，300g离心15分钟，以10毫升培养液重悬并培养到一个单独的培养瓶中。 |
| 年龄（性别） | 男性；50岁 |
| 组织来源 | 前列腺；左锁骨淋巴结癌转移灶 |
| 细胞类型 | 肿瘤细胞 |
| 肿瘤类型 | 前列腺癌细胞 |
| 生物安全等级 | BSL-1 |
| 倍增时间 | ~32-36 hours |
| 致瘤性 | Yes, in soft agar.Yes, the cells are tumorigenic in nude mice. |
| 受体表达情况 | androgen receptor, positive;estrogen receptor, positive |
| 基因表达情况 | human prostatic acid phosphatase; prostate specific antigen |
| 保藏机构 | ATCC; CRL-1740 BCRC; 60088 BCRJ; 0149 ECACC; 89110211 |
STR鉴定
-
STR位点信息
Amelogenin X,Y CSF1PO 10,11 D2S1338 16 D3S1358 16 D5S818 11,12 D7S820 9.1,10.3 D8S1179 12,13,14 D13S317 10,12 D16S539 11 D18S51 11,12 D19S433 13.2,15 D21S11 29,32.2 FGA 19,20 PentaD 12,12.4 PentaE 12,16 TH01 9 TPOX 8,9 vWA 16,18 D6S1043 11,12,18 D12S391 21,22 D2S441 11.3 -
STR鉴定图
-
参考文献
-
β-hydroxybutyrate inhibits malignant phenotypes of prostate cancer cells through β-hydroxybutyrylation of indoleacetamide-N-methyltransferase (2024-03-30)
作者：Yifan Zhang:1.Department of Urology, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Erqi District, Zhengzhou, Henan, Henan, 450000, China. zyf840918@163.com. ; Yunlong Li:1.Department of Urology, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Erqi District, Zhengzhou, Henan, Henan, 450000, China. ;
期刊：β-hydroxybutyrate inhibits malignant phenotypes of prostate cancer cells through β-hydroxybutyrylation of indoleacetamide-N-methyltransferase
DOI：10.1186/s12935-024-03277-6
影响因子 ：5.8
引用产品： PC-3 细胞 , LNCaP clone FGC 细胞
-
PLA inhibits TNF-α-induced PANoptosis of prostate cancer cells through metabolic reprogramming (2024-02-24)
作者：Yinghui Hao:1.Department of Biochemistry and Molecular Biology, School of Medicine, Jinan University, Guangzhou, Guangdong 510632, China. ; Fangmei Xie:1.Department of Biochemistry and Molecular Biology, School of Medicine, Jinan University, Guangzhou, Guangdong 510632, China. ; Jieyi He:1.Department of Biochemistry and Molecular Biology, School of Medicine, Jinan University, Guangzhou, Guangdong 510632, China. ; Chenqiong Gu:1.Department of Biochemistry and Molecular Biology, School of Medicine, Jinan University, Guangzhou, Guangdong 510632, China. ; Ying Zhao:1.Central Laboratory of Panyu Central Hospital, Guangzhou, China. ; Wenfeng Luo:1.Central Laboratory of Panyu Central Hospital, Guangzhou, China. ; Xiaoyu Song:1.Central Laboratory of Panyu Central Hospital, Guangzhou, China. ; Jian Shen:1.Central Laboratory of Panyu Central Hospital, Guangzhou, China. ; Li Yu:1.Department of Biochemistry and Molecular Biology, School of Medicine, Jinan University, Guangzhou, Guangdong 5
期刊：PLA inhibits TNF-α-induced PANoptosis of prostate cancer cells through metabolic reprogramming
DOI：10.1016/j.biocel.2024.106554
影响因子 ：4.0
引用产品： DU 145 细胞 , PC-3M 细胞 , LNCaP clone FGC 细胞
-
A morpholine derivative N-(4-morpholinomethylene)ethanesulfonamide induces ferroptosis in tumor cells by targeting NRF2 (2024-01-30)
作者：Bingchun Sun:1.First Affiliated Hospital of Jinan University. ; Ligang Zhang:1.School of Medicine, Foshan University. ; Binhua Wu:1.Department of Obstetrics and Gynecology of Affiliated Hospital, the Marine Biomedical Research Institute, Guangdong Medical University. ; Xiping Luo:1.First Affiliated Hospital of Jinan University. ; 2.Department of Gynecology, Guangdong Women and Children Hospital. ;
期刊：A morpholine derivative N-(4-morpholinomethylene)ethanesulfonamide induces ferroptosis in tumor cells by targeting NRF2
影响因子 ：2.0
引用产品： 22RV1 细胞 , LNCaP clone FGC 细胞 , C4-2 细胞 , SK-OV-3 细胞
-
Galaxolide and Irgacure 369 are novel environmental androgens (2023-03-09)
作者：Mingzhao Li:1.Shenzhen Key Laboratory of Steroid Drug Discovery and Development, School of Medicine, The Chinese University of Hong Kong, Shenzhen, Guangdong, 518172, China. ; Ren Wang:1.Shenzhen Key Laboratory of Steroid Drug Discovery and Development, School of Medicine, The Chinese University of Hong Kong, Shenzhen, Guangdong, 518172, China. ; Pan Wang:1.Shenzhen Key Laboratory of Steroid Drug Discovery and Development, School of Medicine, The Chinese University of Hong Kong, Shenzhen, Guangdong, 518172, China. Electronic address: wangpan@cuhk.edu.cn. ;
期刊：Galaxolide and Irgacure 369 are novel environmental androgens
DOI：10.1016/j.chemosphere.2023.138329
影响因子 ：8.8
引用产品： 特级胎牛血清 , LNCaP clone FGC 细胞
-
ATXN3 promotes prostate cancer progression by stabilizing YAP (2023-06-22)
作者：Longxiang Wu:1.Department of Urology, Xiangya Hospital, Central South University, Changsha, China. ; Zhenyu Ou:1.Department of Urology, Xiangya Hospital, Central South University, Changsha, China. ; Peihua Liu:1.Department of Urology, Xiangya Hospital, Central South University, Changsha, China. ; Cheng Zhao:1.Department of Urology, Xiangya Hospital, Central South University, Changsha, China. ; Shiyu Tong:1.Department of Urology, Xiangya Hospital, Central South University, Changsha, China. ; Ruizhe Wang:1.Department of Urology, Xiangya Hospital, Central South University, Changsha, China. ; Yangle Li:1.Department of Urology, Xiangya Hospital, Central South University, Changsha, China. ; Junbin Yuan:1.Department of Urology, Xiangya Hospital, Central South University, Changsha, China. ; Minfeng Chen:1.Department of Urology, Xiangya Hospital, Central South University, Changsha, China. ; Benyi Fan:1.Department of Urology, Xiangya Hospital, Central South University, Changsha, China.
期刊：ATXN3 promotes prostate cancer progression by stabilizing YAP
DOI：10.1186/s12964-023-01073-9
影响因子 ：8.4
引用产品： LNCaP clone FGC 细胞 , C4-2 细胞 , 293T [HEK-293T] 细胞
-
ND630 controls ACACA and lipid reprogramming in prostate cancer by regulating the expression of circKIF18B_003 (2023-12-04)
作者：Yu-Peng Wu:1.Department of Urology, Urology Research Institute, The First Affiliated Hospital, Fujian Medical University, 20 Chazhong Road, Fuzhou, 350005, China. ; 2.Department of Urology, National Region Medical Centre, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350212, China. ; Wen-Cai Zheng:1.Department of Urology, Urology Research Institute, The First Affiliated Hospital, Fujian Medical University, 20 Chazhong Road, Fuzhou, 350005, China. ; 2.Department of Urology, National Region Medical Centre, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350212, China. ; Qi Huang:1.Department of Urology, Urology Research Institute, The First Affiliated Hospital, Fujian Medical University, 20 Chazhong Road, Fuzhou, 350005, China. ; 2.Department of Urology, National Region Medical Centre, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350212, China. ; Xu-Yun Huang:1.Department of U
期刊：ND630 controls ACACA and lipid reprogramming in prostate cancer by regulating the expression of circKIF18B_003
DOI：10.1186/s12967-023-04760-w
影响因子 ：7.4
引用产品： PC-3 细胞 , DU 145 细胞 , LNCaP clone FGC 细胞 , RWPE-1 细胞 , 293T [HEK-293T] 细胞
-
Triggering pyroptosis enhances the antitumor efficacy of PARP inhibitors in prostate cancer (2023-08-23)
作者：Ao Tian:1.State Key Laboratory of Systems Medicine for Cancer, Renji Hospital, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, 1954 Huashan Road, Shanghai, 200030, China. ; Tingyu Wu:1.State Key Laboratory of Systems Medicine for Cancer, Renji Hospital, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, 1954 Huashan Road, Shanghai, 200030, China. ; Yanshuang Zhang:1.State Key Laboratory of Systems Medicine for Cancer, Renji Hospital, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, 1954 Huashan Road, Shanghai, 200030, China. ; Jiachen Chen:1.State Key Laboratory of Systems Medicine for Cancer, Renji Hospital, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, 1954 Huashan Road, Shanghai, 200030, China. ; Jianjun Sha:1.Department of Urology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 145 Shandong Middle road
期刊：Triggering pyroptosis enhances the antitumor efficacy of PARP inhibitors in prostate cancer
DOI：10.1007/s13402-023-00860-3
影响因子 ：6.6
引用产品： LNCaP clone FGC 细胞 , WPMY-1 细胞
-
Identification and validation of a novel overall survival prediction model for immune-related genes in bone metastases of prostate cancer (2023-07-25)
作者：Wen Bi:1.Department of Sports Medicine, Huazhong University of Science and Technology Union Shenzhen Hospital, The 6th Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, China. ; Weiming Guo:1.Department of Sports Medicine, Huazhong University of Science and Technology Union Shenzhen Hospital, The 6th Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, China. ; Gang Fan:1.Department of Urology, Huazhong University of Science and Technology Union Shenzhen Hospital, The 6th Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, China. ; Lei Xie:1.Department of Urology, Huazhong University of Science and Technology Union Shenzhen Hospital, The 6th Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, China. ; Changqing Jiang:1.Department of Sports Medicine, Huazhong University of Science and Technology Union Shenzhen Hospital, The 6th Affiliated Hospital of Shenzhen University Health Science Ce
期刊：Identification and validation of a novel overall survival prediction model for immune-related genes in bone metastases of prostate cancer
影响因子 ：5.2
引用产品： PC-3 细胞 , DU 145 细胞 , LNCaP clone FGC 细胞 , 22RV1 细胞 , RPMI-1640 培养基
-
Cuproptosis enhances docetaxel chemosensitivity by inhibiting autophagy via the DLAT/mTOR pathway in prostate cancer (2023-08-16)
作者：Hongzhuang Wen:1.Department of Urology, The Second Hospital of Hebei Medical University, Shijiazhuang, China. ; Changbao Qu:1.Department of Urology, The Second Hospital of Hebei Medical University, Shijiazhuang, China. ; Zhu Wang:1.Department of Urology, The Second Hospital of Hebei Medical University, Shijiazhuang, China. ; Haitao Gao:1.Department of Urology, The Second Hospital of Hebei Medical University, Shijiazhuang, China. ; Wuyao Liu:1.Department of Urology, The Second Hospital of Hebei Medical University, Shijiazhuang, China. ; Hu Wang:1.Department of Urology, The Second Hospital of Hebei Medical University, Shijiazhuang, China. ; Hao Sun:1.Department of Urology, The Second Hospital of Hebei Medical University, Shijiazhuang, China. ; Junfei Gu:1.Department of Urology, The Second Hospital of Hebei Medical University, Shijiazhuang, China. ; Zhan Yang:1.Department of Urology, The Second Hospital of Hebei Medical University, Shijiazhuang, China. ; 2.Molecular Biology Labora
期刊：Cuproptosis enhances docetaxel chemosensitivity by inhibiting autophagy via the DLAT/mTOR pathway in prostate cancer
影响因子 ：4.8
引用产品： LNCaP clone FGC 细胞 , PC-3 细胞 , 22RV1 细胞
-
Analyzing roles of small nucleolar RNA host gene 25 from clinical, molecular target and tumor formation in prostate cancer (2023-06-10)
作者：Zelin Liu:1.Department of Urology, Renmin Hospital of Wuhan University, Wuhan, 430060, China; Britton Chance Center for Biomedical Photonics, Wuhan National Laboratory for Optoelectronics, Huazhong University of Science and Technology, Wuhan, 430074, China. ; Shuai Ke:1.Department of Urology, Renmin Hospital of Wuhan University, Wuhan, 430060, China. ; Qinghua Wang:1.Department of Urology, Renmin Hospital of Wuhan University, Wuhan, 430060, China. ; Xuhang Gu:1.School of Minerals Processing and Bioengineering, Central South University, Changsha, 410000, China. ; Guanzhong Zhai:1.Department of Urology, Renmin Hospital of Wuhan University, Wuhan, 430060, China. ; Haoren Shao:1.Department of Urology, Renmin Hospital of Wuhan University, Wuhan, 430060, China. ; Mu He:1.Department of Urology, Renmin Hospital of Wuhan University, Wuhan, 430060, China. ; Jia Guo:1.Department of Urology, Renmin Hospital of Wuhan University, Wuhan, 430060, China. Electronic address: doctor_zelin@hust.edu
期刊：Analyzing roles of small nucleolar RNA host gene 25 from clinical, molecular target and tumor formation in prostate cancer
DOI：10.1016/j.yexcr.2023.113686
影响因子 ：3.7
引用产品： PC-3 细胞 , LNCaP clone FGC 细胞 , DU 145 细胞 , WPMY-1 细胞
-
A cuproptosis-related LncRNA signature: Integrated analysis associated with biochemical recurrence and immune landscape in prostate cancer (2023-02-24)
作者：Lei Ren:1.Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University, Guangzhou, China. ; Xu Yang:1.Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University, Guangzhou, China. ; Weifeng Wang:1.Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University, Guangzhou, China. ; Hansen Lin:1.Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University, Guangzhou, China. ; Guankai Huang:1.Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University, Guangzhou, China. ; Zixiong Liu:1.Department of Urology, The Seventh Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University, Shenzhen, China. ; Jincheng Pan:1.Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University, Guangzhou, China. ; Xiaopeng Mao:1.Department of Ur
期刊：A cuproptosis-related LncRNA signature: Integrated analysis associated with biochemical recurrence and immune landscape in prostate cancer
DOI：10.3389/fgene.2023.1096783
影响因子 ：3.7
引用产品： PC-3 细胞 , DU 145 细胞 , LNCaP clone FGC 细胞 , RWPE-1 细胞
-
A Prognostic Model for Prostate Cancer Patients Based on Two DNA Damage Response Mutation-Related Immune Genes (2023-08-22)
作者：Jian Wang:1.Department of Urology Surgery, The First People's Hospital of Foshan, Affiliated Hospital of Sun Yat-sen University, Foshan City, China. ; Li Jiang:1.Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. ; Zhenhua Shang:1.Department of Urology, Xuan Wu Hospital Capital Medical University, Beijing, China. ; Zhaohua Ye:1.Department of Urology Surgery, The People's Hospital of Dongguan, Dongguan City, China. ; Dan Yuan:1.Department of Urology, Jiangmen Central Hospital, Jiangmen, China. ; Xin Cui:1.Department of Urology, Xuan Wu Hospital Capital Medical University, Beijing, China. ;
期刊：A Prognostic Model for Prostate Cancer Patients Based on Two DNA Damage Response Mutation-Related Immune Genes
影响因子 ：3.4
引用产品： DU 145 细胞 , LNCaP clone FGC 细胞
-
IU1 and enzalutamide combination yields synergistic effects on castration-resistant prostate cancer (2023-08-07)
作者：Yifan Zhang:1.Department of Urology, Nanfang Hospital, Southern Medical University, Guangdong, Guangzhou, China. ; Yuanpeng Liao:1.Department of Urology, Nanfang Hospital, Southern Medical University, Guangdong, Guangzhou, China. ; Mayao Luo:1.Department of Urology, Nanfang Hospital, Southern Medical University, Guangdong, Guangzhou, China. ; Yuedian Ye:1.Department of Urology, Nanfang Hospital, Southern Medical University, Guangdong, Guangzhou, China. ; Zhuofan Xu:1.Department of Urology, Nanfang Hospital, Southern Medical University, Guangdong, Guangzhou, China. ; Wenli Hou:1.Department of Urology, Nanfang Hospital, Southern Medical University, Guangdong, Guangzhou, China. ; Ruiyu Liu:1.Department of Urology, Nanfang Hospital, Southern Medical University, Guangdong, Guangzhou, China. ; Qiliang Zhai:1.Department of Urology, Nanfang Hospital, Southern Medical University, Guangdong, Guangzhou, China. ; Shidong Lv:1.Department of Urology, Nanfang Hospital, Southern Medical Univer
期刊：IU1 and enzalutamide combination yields synergistic effects on castration-resistant prostate cancer
影响因子 ：2.8
引用产品： LNCaP clone FGC 细胞 , C4-2 细胞 , 22RV1 细胞 , PC-3 细胞
-
Exploring the role of differentially expressed metabolic genes and their mechanisms in bone metastatic prostate cancer (2023-04-12)
作者：Qingfu Zhang:1.Department of Urology, Tai 'an Central Hospital, Tai 'an, Shandong, China. ; Peng Zhang:1.Department of Spine Surgery, Tai 'an Central Hospital, Tai 'an, Shandong, China. ; Zhongting Zhao:1.Department of Spinal Surgery, The Third People's Hospital of Jinan, Jinan, Shandong, China. ; Jun Wang:1.Department of Emergency, Qingdao Eighth People's Hospital, Qingdao, China. ; Hepeng Zhang:1.Department of Urology, Tai 'an Central Hospital, Tai 'an, Shandong, China. ;
期刊：Exploring the role of differentially expressed metabolic genes and their mechanisms in bone metastatic prostate cancer
影响因子 ：2.7
引用产品： PC-3 细胞 , DU 145 细胞 , LNCaP clone FGC 细胞 , 22RV1 细胞
-
Circ_0005276 Promotes Prostate Cancer Progression Through the Crosstalk of miR-128-3p/DEPDC1B Axis (2023-03-13)
作者：Wenwei Li:1.Department of Urology WardIII, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Edong Healthcare Group, No.293, Feiyun Street, Huangshi, 435000, Hubei Province, China. ; 2.Hubei Key Laboratory of Kidney Disease Pathogenesis and Intervention, Wuhan, China. ; Wenbing Wu:1.Department of Urology WardIII, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Edong Healthcare Group, No.293, Feiyun Street, Huangshi, 435000, Hubei Province, China. hszxyy1193868501@163.com. ; 2.Hubei Key Laboratory of Kidney Disease Pathogenesis and Intervention, Wuhan, China. hszxyy1193868501@163.com. ;
期刊：Circ_0005276 Promotes Prostate Cancer Progression Through the Crosstalk of miR-128-3p/DEPDC1B Axis
DOI：10.1007/s10528-022-10328-y
影响因子 ：2.4
引用产品： LNCaP clone FGC 细胞 , DU 145 细胞 , RPMI-1640 培养基 , 特级胎牛血清 , RWPE-1 细胞 , K-SFM 培养基 , EGF/Urogastrone/URG, Human, Recombinant
-
Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer (2022-09-01)
作者：Shidong Lv:1.Department of Urology, Nanfang Hospital, Southern Medical University-Guangzhou, Guangzhou, China. ; 2.Department of Urology, University of Pittsburgh School of Medicine-Pittsburgh, Pittsburgh, PA, USA. ; Zeyu Wu:1.Department of Urology, University of Pittsburgh School of Medicine-Pittsburgh, Pittsburgh, PA, USA. ; 2.Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University-Changsha, Changsha, China. ; Mayao Luo:1.Department of Urology, Nanfang Hospital, Southern Medical University-Guangzhou, Guangzhou, China. ; Yifan Zhang:1.Department of Urology, Nanfang Hospital, Southern Medical University-Guangzhou, Guangzhou, China. ; Jianqiang Zhang:1.Department of Urology, Nanfang Hospital, Southern Medical University-Guangzhou, Guangzhou, China. ; 2.Department of urology surgery department ward III, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine-Nanning, Guangxi, China. ; Laura E Pascal:1.Department of Urology, University of
期刊：Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer
DOI：10.1038/s41419-022-05182-0
影响因子 ：9.7
引用产品： LNCaP clone FGC 细胞 , VCaP 细胞 , 22RV1 细胞
-
Tautomycin and enzalutamide combination yields synergistic effects on castration-resistant prostate cancer (2022-11-29)
作者：Mayao Luo:1.Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China. ; Yifan Zhang:1.Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China. ; Zhuofan Xu:1.Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China. ; Chenwei Wu:1.Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China. ; Yuedian Ye:1.Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China. ; Rui Liu:1.School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, 510515, China. liurui2011hgd@163.com. ; Shidong Lv:1.Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China. lsd990@163.com. ; Qiang Wei:1.Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515
期刊：Tautomycin and enzalutamide combination yields synergistic effects on castration-resistant prostate cancer
DOI：10.1038/s41420-022-01257-1
影响因子 ：7.1
引用产品： LNCaP clone FGC 细胞 , C4-2 细胞 , 22RV1 细胞
-
HMGB1 promotes the development of castration‑resistant prostate cancer by regulating androgen receptor activation (2022-09-19)
作者：Junyu Chen:1.Department of Rehabilitation, School of Nursing, Jilin University, Changchun, Jilin 130021, P.R. China. ; Duo Xu:1.Department of Rehabilitation, School of Nursing, Jilin University, Changchun, Jilin 130021, P.R. China. ; Taiwei Wang:1.Department of Rehabilitation, School of Nursing, Jilin University, Changchun, Jilin 130021, P.R. China. ; Zhaoyun Yang:1.Department of Rehabilitation, School of Nursing, Jilin University, Changchun, Jilin 130021, P.R. China. ; Yanrong Yang:1.School of Medicine, Tongji University, Shanghai 200092, P.R. China. ; Kang He:1.Department of Rehabilitation, School of Nursing, Jilin University, Changchun, Jilin 130021, P.R. China. ; Lijing Zhao:1.Department of Rehabilitation, School of Nursing, Jilin University, Changchun, Jilin 130021, P.R. China. ;
期刊：HMGB1 promotes the development of castration‑resistant prostate cancer by regulating androgen receptor activation
影响因子 ：4.1
引用产品： LNCaP clone FGC 细胞 , 22RV1 细胞
-
GPX2 predicts recurrence-free survival and triggers the Wnt/β-catenin/EMT pathway in prostate cancer (2022-10-25)
作者：Ming Yang:1.The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China. ; Xudong Zhu:1.The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China. ; Yang Shen:1.The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China. ; Qi He:1.The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China. ; Yuan Qin:1.The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China. ; Yiqun Shao:1.Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China. ; Lin Yuan:1.Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China. ; Hesong Ye:1.The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China. ;
期刊：GPX2 predicts recurrence-free survival and triggers the Wnt/β-catenin/EMT pathway in prostate cancer
影响因子 ：3.1
引用产品： PC-3 细胞 , DU 145 细胞 , LNCaP clone FGC 细胞 , 22RV1 细胞
-
Circ_0044516 Enriches the Level of SARM1 as a miR-330-5p Sponge to Regulate Cell Malignant Behaviors and Tumorigenesis of Prostate Cancer (2001-02-20)
作者：Yan Wu:1.Department of Urology, Section 4, People's Hospital of Hunan Province, No.89, Guhan Road, Furong District, Changsha, 410002, Hunan, China. vmm77dk@163.com. ;
期刊：Circ_0044516 Enriches the Level of SARM1 as a miR-330-5p Sponge to Regulate Cell Malignant Behaviors and Tumorigenesis of Prostate Cancer
DOI：10.1007/s10528-021-10160-w
影响因子 ：2.4
引用产品： DU 145 细胞 , LNCaP clone FGC 细胞 , DMEM高糖完全培养基 (含10%FBS) , RPMI-1640完全培养基 (含10%FBS) , RWPE-1 细胞
-
LOC100996425 acts as a promoter in prostate cancer by mediating hepatocyte nuclear factor 4A and the AMPK/mTOR pathway (2008-01-20)
作者：Xiuyan Wang:1.Department of Urology, The Second Hospital of Jilin University, Changchun, China. ; Bin Song:1.Department of Neurosurgery, The Second Hospital of Jilin University, Changchun, China. ; Mingcui Zang:1.Department of Hepatobiliary and Pancreatic Surgery I, The First Hospital of Jilin University, Changchun, China. ; He Ji:1.Department of Gynaecology, The Second Hospital of Jilin University, Changchun, China. ; He Yang:1.Department of Urology, The Second Hospital of Jilin University, Changchun, China. ; Shuang Jiang:1.Department of Urology, The Second Hospital of Jilin University, Changchun, China. ; Xiao Yang:1.Department of Urology, The Second Hospital of Jilin University, Changchun, China. ;
期刊：LOC100996425 acts as a promoter in prostate cancer by mediating hepatocyte nuclear factor 4A and the AMPK/mTOR pathway
影响因子 ：5.3
引用产品： C4-2 细胞 , PC-3 细胞 , 22RV1 细胞 , LNCaP clone FGC 细胞 , DU 145 细胞
-
MET inhibition enhances PARP inhibitor efficacy in castration-resistant prostate cancer by suppressing the ATM/ATR and PI3K/AKT pathways (2011-01-20)
作者：Sihai Zhou:1.Department of Urology, The Second Affiliated Hospital of Dalian Medical University, DaLian, China. ; Zhihong Dai:1.Department of Urology, The Second Affiliated Hospital of Dalian Medical University, DaLian, China. ; Liang Wang:1.Department of Urology, The Second Affiliated Hospital of Dalian Medical University, DaLian, China. ; Xiang Gao:1.Department of Urology, The Second Affiliated Hospital of Dalian Medical University, DaLian, China. ; Liqin Yang:1.Department of Urology, The Second Affiliated Hospital of Dalian Medical University, DaLian, China. ; Zhenwei Wang:1.Department of Urology, Guangdong Second Provincial General Hospital, Guangzhou, China. ; Qi Wang:1.Department of Respiratory Medicine, The Second Affiliated Hospital of Dalian Medical University, DaLian, China. ; Zhiyu Liu:1.Department of Urology, The Second Affiliated Hospital of Dalian Medical University, DaLian, China. ;
期刊：MET inhibition enhances PARP inhibitor efficacy in castration-resistant prostate cancer by suppressing the ATM/ATR and PI3K/AKT pathways
影响因子 ：5.3
引用产品： DU 145 细胞 , PC-3 细胞 , LNCaP clone FGC 细胞 , 22RV1 细胞
-
Hsa_circ_0074032 promotes prostate cancer progression through elevating homeobox A1 expression by serving as a microRNA-198 decoy (2011-01-20)
作者：Chuanshun Feng:1.Department of Urology, Shenzhen Longhua District Central Hospital, Shenzhen City, China. ; Qinjun Wang:1.Department of Urology, Shenzhen Longhua District Central Hospital, Shenzhen City, China. ; Ling Deng:1.Department of Urology, Shenzhen Longhua District Central Hospital, Shenzhen City, China. ; Naixiong Peng:1.Department of Urology, Shenzhen Longhua District Central Hospital, Shenzhen City, China. ; Minlong Yang:1.Department of Urology, Shenzhen Longhua District Central Hospital, Shenzhen City, China. ; Xisheng Wang:1.Department of Urology, Shenzhen Longhua District Central Hospital, Shenzhen City, China. ;
期刊：Hsa_circ_0074032 promotes prostate cancer progression through elevating homeobox A1 expression by serving as a microRNA-198 decoy
影响因子 ：2.4
引用产品： LNCaP clone FGC 细胞 , PC-3 细胞 , DU 145 细胞 , RPMI-1640 培养基 , Ham's F-12K 培养基 , MEM (含NEAA) 培养基 , 特级胎牛血清 , 青霉素-链霉素溶液 (双抗)，100× , RWPE-1 细胞 , RWPE-1细胞专用培养基
-
Novel gadopentetic acid-doped silica nanoparticles conjugated with YPSMA-1 targeting prostate cancer for MR imaging: an in vitro study (2003-08-20)
作者：Wei Jiang:1.Department of Radiology, The Second Affiliated Hospital of Chongqing Medical University, No. 74 Linjiang Rd, Yuzhong District, 400010, Chongqing, China; Institute of Ultrasound Imaging, Department of Ultrasound, Second Affiliated Hospital of Chongqing Medical University, No. 74 Linjiang Rd, Yuzhong District, 400010, Chongqing, China. ; Xiaojing He:1.Department of Radiology, The Second Affiliated Hospital of Chongqing Medical University, No. 74 Linjiang Rd, Yuzhong District, 400010, Chongqing, China. ; Huiying Fang:1.Department of Breast Diseases, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, No. 181 Hanyu Rd, Shapingba District, 400030, Chongqing, China. ; Xue Zhou:1.Department of Radiology, The Second Affiliated Hospital of Chongqing Medical University, No. 74 Linjiang Rd, Yuzhong District, 400010, Chongqing, China. ; Haitao Ran:1.Institute of Ultrasound Imaging, Department of Ultrasound, Second Affiliated Hospital of Ch
期刊：Novel gadopentetic acid-doped silica nanoparticles conjugated with YPSMA-1 targeting prostate cancer for MR imaging: an in vitro study
DOI：10.1016/j.bbrc.2018.03.124
影响因子 ：3.1
引用产品： LNCaP clone FGC 细胞 , PC-3 细胞
FAQs
Q：{{item.question}}
A：
产品资料
识别码示意图
